End-of-day quote
Shanghai S.E.
23:00:00 25/04/2024 BST
|
5-day change
|
1st Jan Change
|
21.2
CNY
|
+2.27%
|
|
-5.02%
|
-14.86%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
15,944
|
27,171
|
51,603
|
33,307
|
37,585
|
24,144
|
24,144
|
-
|
Enterprise Value (EV)
1 |
15,944
|
25,784
|
49,252
|
32,838
|
36,233
|
22,776
|
22,422
|
21,960
|
P/E ratio
|
30
x
|
41.5
x
|
48.4
x
|
42.1
x
|
36.3
x
|
18.4
x
|
15
x
|
12.3
x
|
Yield
|
1.51%
|
1.15%
|
1.02%
|
1.19%
|
1.52%
|
2.73%
|
3.3%
|
3.91%
|
Capitalization / Revenue
|
1.8
x
|
2.44
x
|
3.54
x
|
1.99
x
|
1.77
x
|
0.98
x
|
0.79
x
|
0.65
x
|
EV / Revenue
|
1.8
x
|
2.31
x
|
3.38
x
|
1.96
x
|
1.71
x
|
0.92
x
|
0.73
x
|
0.59
x
|
EV / EBITDA
|
16.7
x
|
21.3
x
|
27.5
x
|
13.6
x
|
19.2
x
|
8.99
x
|
7.41
x
|
6.16
x
|
EV / FCF
|
-
|
21.2
x
|
42
x
|
117
x
|
13.1
x
|
8.49
x
|
10.2
x
|
8.43
x
|
FCF Yield
|
-
|
4.71%
|
2.38%
|
0.86%
|
7.61%
|
11.8%
|
9.85%
|
11.9%
|
Price to Book
|
5.24
x
|
6.65
x
|
9.93
x
|
6.3
x
|
6.24
x
|
3.48
x
|
2.99
x
|
2.61
x
|
Nbr of stocks (in thousands)
|
1,078,303
|
1,078,303
|
1,138,102
|
1,138,968
|
1,138,947
|
1,138,846
|
1,138,846
|
-
|
Reference price
2 |
14.79
|
25.20
|
45.34
|
29.24
|
33.00
|
21.20
|
21.20
|
21.20
|
Announcement Date
|
04/03/19
|
28/04/20
|
19/04/21
|
27/04/22
|
27/04/23
|
-
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
8,859
|
11,141
|
14,583
|
16,759
|
21,248
|
24,720
|
30,582
|
37,311
|
EBITDA
1 |
956
|
1,211
|
1,788
|
2,408
|
1,883
|
2,532
|
3,026
|
3,563
|
EBIT
1 |
718.3
|
918.3
|
1,448
|
1,041
|
1,421
|
1,868
|
2,293
|
2,779
|
Operating Margin
|
8.11%
|
8.24%
|
9.93%
|
6.21%
|
6.69%
|
7.56%
|
7.5%
|
7.45%
|
Earnings before Tax (EBT)
1 |
719.6
|
919.5
|
1,446
|
1,044
|
1,415
|
1,807
|
2,237
|
2,712
|
Net income
1 |
531.6
|
702.7
|
1,062
|
791.2
|
1,036
|
1,303
|
1,627
|
1,975
|
Net margin
|
6%
|
6.31%
|
7.28%
|
4.72%
|
4.87%
|
5.27%
|
5.32%
|
5.29%
|
EPS
2 |
0.4934
|
0.6076
|
0.9375
|
0.6944
|
0.9083
|
1.152
|
1.414
|
1.717
|
Free Cash Flow
1 |
-
|
1,214
|
1,174
|
281.7
|
2,759
|
2,683
|
2,208
|
2,606
|
FCF margin
|
-
|
10.9%
|
8.05%
|
1.68%
|
12.99%
|
10.85%
|
7.22%
|
6.99%
|
FCF Conversion (EBITDA)
|
-
|
100.27%
|
65.67%
|
11.7%
|
146.56%
|
105.96%
|
72.99%
|
73.16%
|
FCF Conversion (Net income)
|
-
|
172.76%
|
110.52%
|
35.6%
|
266.4%
|
205.83%
|
135.78%
|
131.96%
|
Dividend per Share
2 |
0.2226
|
0.2894
|
0.4630
|
0.3472
|
0.5000
|
0.5788
|
0.6989
|
0.8288
|
Announcement Date
|
04/03/19
|
28/04/20
|
19/04/21
|
27/04/22
|
27/04/23
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q2
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
3,996
|
4,301
|
4,404
|
4,677
|
5,044
|
5,097
|
6,430
|
5,947
|
6,045
|
5,731
|
6,760
|
6,842
|
7,121
|
7,384
|
8,553
|
EBITDA
1 |
385.2
|
300.5
|
-
|
614
|
498.6
|
426.9
|
-
|
-
|
-
|
-
|
546.7
|
929.6
|
976.8
|
976.8
|
1,024
|
EBIT
1 |
400.8
|
224.4
|
-41.44
|
492.4
|
438.9
|
291.9
|
197.6
|
684.1
|
576.8
|
371.6
|
181.5
|
540.5
|
553.6
|
580.6
|
637.3
|
Operating Margin
|
10.03%
|
5.22%
|
-0.94%
|
10.53%
|
8.7%
|
5.73%
|
3.07%
|
11.5%
|
9.54%
|
6.48%
|
2.69%
|
7.9%
|
7.77%
|
7.86%
|
7.45%
|
Earnings before Tax (EBT)
1 |
396
|
224.7
|
-34.41
|
493.8
|
443.4
|
288.6
|
189
|
679.4
|
547.3
|
363.7
|
165.4
|
509.5
|
553.8
|
553.8
|
598.1
|
Net income
1 |
305.1
|
172.7
|
-27.1
|
384.2
|
330
|
209.1
|
112.5
|
496.8
|
420.7
|
256.9
|
97.33
|
470
|
401.1
|
401.1
|
433.2
|
Net margin
|
7.64%
|
4.02%
|
-0.62%
|
8.22%
|
6.54%
|
4.1%
|
1.75%
|
8.35%
|
6.96%
|
4.48%
|
1.44%
|
6.87%
|
5.63%
|
5.43%
|
5.06%
|
EPS
2 |
0.2708
|
0.1597
|
-0.0347
|
0.3403
|
0.2848
|
0.1833
|
0.1000
|
0.4333
|
0.3767
|
0.2200
|
0.0985
|
0.3159
|
0.3029
|
0.3075
|
0.4462
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.5906
|
-
|
-
|
Announcement Date
|
29/08/21
|
27/10/21
|
27/04/22
|
27/04/22
|
29/08/22
|
27/10/22
|
27/04/23
|
27/04/23
|
29/08/23
|
30/10/23
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
1,387
|
2,351
|
469
|
1,352
|
1,368
|
1,721
|
2,183
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
1,214
|
1,174
|
282
|
2,759
|
2,683
|
2,209
|
2,607
|
ROE (net income / shareholders' equity)
|
18.5%
|
20.4%
|
22.7%
|
14.6%
|
17.9%
|
19.5%
|
21%
|
22.1%
|
ROA (Net income/ Total Assets)
|
7.75%
|
9.24%
|
10.1%
|
5.33%
|
5.43%
|
6.2%
|
6.83%
|
7.03%
|
Assets
1 |
6,860
|
7,605
|
10,502
|
14,834
|
19,088
|
21,024
|
23,833
|
28,083
|
Book Value Per Share
2 |
2.820
|
3.790
|
4.560
|
4.640
|
5.290
|
6.090
|
7.090
|
8.110
|
Cash Flow per Share
2 |
0.8100
|
1.530
|
1.720
|
1.370
|
3.300
|
2.190
|
2.320
|
2.820
|
Capex
1 |
549
|
494
|
780
|
1,273
|
997
|
876
|
908
|
1,291
|
Capex / Sales
|
6.2%
|
4.43%
|
5.35%
|
7.6%
|
4.69%
|
3.55%
|
2.97%
|
3.46%
|
Announcement Date
|
04/03/19
|
28/04/20
|
19/04/21
|
27/04/22
|
27/04/23
|
-
|
-
|
-
|
Last Close Price
21.2
CNY Average target price
33.62
CNY Spread / Average Target +58.61% Consensus |
1st Jan change
|
Capi.
|
---|
| -14.86% | 3.33B | | -32.21% | 15.27B | | -31.97% | 10.84B | | -30.42% | 6.06B | | +8.14% | 6.04B | | -11.41% | 5.86B | | -0.88% | 4.71B | | +52.19% | 4.29B | | -12.31% | 3.61B | | -6.93% | 3.01B |
Other Drug Retailers
|